Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Abvc Biopharma (ABVC) over the last 12 years, with Q3 2025 value amounting to -$112553.0.

  • Abvc Biopharma's Other Non Operating Income fell 46988.73% to -$112553.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $102584.0, marking a year-over-year decrease of 192.64%. This contributed to the annual value of $134443.0 for FY2024, which is 49252.09% up from last year.
  • As of Q3 2025, Abvc Biopharma's Other Non Operating Income stood at -$112553.0, which was down 46988.73% from $136148.0 recorded in Q2 2025.
  • In the past 5 years, Abvc Biopharma's Other Non Operating Income registered a high of $557105.0 during Q4 2021, and its lowest value of -$277328.0 during Q4 2022.
  • Over the past 5 years, Abvc Biopharma's median Other Non Operating Income value was $951.0 (recorded in 2021), while the average stood at $19409.4.
  • Per our database at Business Quant, Abvc Biopharma's Other Non Operating Income skyrocketed by 3581185.9% in 2021 and then plummeted by 75325.7% in 2022.
  • Quarter analysis of 5 years shows Abvc Biopharma's Other Non Operating Income stood at $557105.0 in 2021, then plummeted by 149.78% to -$277328.0 in 2022, then surged by 128.24% to $78315.0 in 2023, then increased by 13.52% to $88901.0 in 2024, then plummeted by 226.6% to -$112553.0 in 2025.
  • Its last three reported values are -$112553.0 in Q3 2025, $136148.0 for Q2 2025, and -$9912.0 during Q1 2025.